NCT01080131 · Interventional trial
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.
Overall registry status Completed
Phase 3
Conditions Acute Gout
Delaware Valley sites
- Philadelphia VA medical Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory